Abstract
The early detection and diagnosis of novel coronavirus disease 2019 (COVID-19) are required to cure the disease. Metaheuristic techniques can be used to develop an automated tool for detecting the symptoms of an infected person and provide appropriate precautionary measures. The metaheuristic-based software can be designed to analyze the radiographic patterns of infected individuals and determine the severity of COVID-19 infection. The genome structure of coronavirus can be easily understood through metaheuristic techniques. Based on the genome structure, an effective drug combination can be explored by using metaheuristics for the treatment of COVID-19.
Keywords: COVID-19, metaheuristic, diagnosis, drug design, social implication, epidemic.
Coronaviruses
Title:Impact of Metaheuristic Techniques in Pandemic of COVID-19
Volume: 2 Issue: 8
Author(s): Vijay Kumar*, Dilbag Singh and Manjit Kaur
Affiliation:
- Computer Science and Engineering Department, National Institute of Technology, Hamirpur, Himachal Pradesh-177005,India
Keywords: COVID-19, metaheuristic, diagnosis, drug design, social implication, epidemic.
Abstract: The early detection and diagnosis of novel coronavirus disease 2019 (COVID-19) are required to cure the disease. Metaheuristic techniques can be used to develop an automated tool for detecting the symptoms of an infected person and provide appropriate precautionary measures. The metaheuristic-based software can be designed to analyze the radiographic patterns of infected individuals and determine the severity of COVID-19 infection. The genome structure of coronavirus can be easily understood through metaheuristic techniques. Based on the genome structure, an effective drug combination can be explored by using metaheuristics for the treatment of COVID-19.
Export Options
About this article
Cite this article as:
Kumar Vijay *, Singh Dilbag and Kaur Manjit , Impact of Metaheuristic Techniques in Pandemic of COVID-19, Coronaviruses 2021; 2 (8) : e260721189257 . https://dx.doi.org/10.2174/2666796701999201218142021
DOI https://dx.doi.org/10.2174/2666796701999201218142021 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clarification of Interaction Mechanism of Mouse Hepatitis Virus (MHV) N and nsp3 Protein with Homology Modeling and Protein-Protein Docking Analysis
Current Computer-Aided Drug Design An Overview on COVID-19 Pandemic: from Discovery to Treatment
Infectious Disorders - Drug Targets <i>In Silico</i> Investigation of the SARS CoV2 Protease with Thymoquinone, the Major Constituent of <i>Nigella Sativa</i>
Current Drug Discovery Technologies Exposure to Perinatal Infections and Bipolar Disorder: A Systematic Review
Current Molecular Medicine Addressing the Importance of Stem Cell-Based Therapy: A Perspective in the Treatment of COVID-19
Current Molecular Medicine Neurological Complications in COVID-19 Patients and its Implications for Associated Mortality
Current Neurovascular Research ACE2 as a Potential Target for Management of Novel Coronavirus (nCoV- 2019)
Current Drug Discovery Technologies The Coronavirus Epidemic
Medicinal Chemistry The Impetus of COVID -19 in Multiple Organ Affliction Apart from Respiratory Infection: Pathogenesis, Diagnostic Measures and Current Treatment Strategy
Infectious Disorders - Drug Targets Pseudotyping Viral Vectors With Emerging Virus Envelope Proteins
Current Gene Therapy <i>In Silico</i> Modeling of Small Molecule Carboxamides as Inhibitors of SARS-CoV 3CL Protease: An Approach Towards Combating COVID-19
Combinatorial Chemistry & High Throughput Screening Combination Therapy with Favipiravir for Treatment of Hospitalized COVID-19 Adults
New Emirates Medical Journal Characterization and Inhibition of SARS-Coronavirus Main Protease
Current Topics in Medicinal Chemistry Updates on the Production of Therapeutic Antibodies Using Human Hybridoma Technique
Current Pharmaceutical Design The Synergic Role of Environmental Contaminants in the Immunological Effects of Viral Diseases, Such as COVID-19
Coronaviruses Heteromerization as a Mechanism Modulating the Affinity of the ACE2 Receptor to the Receptor Binding Domain of SARS-CoV-2 Spike Protein
Current Proteomics The Use of Lectins as Tools to Combat SARS-CoV-2
Current Pharmaceutical Design Cell Penetrating Peptide Delivery of Splice Directing Oligonucleotides as a Treatment for Duchenne Muscular Dystrophy
Current Pharmaceutical Design Environmental Risk Assessment of Replication Competent Viral Vectors Applied in Clinical Trials: Potential Effects of Inserted Sequences
Current Gene Therapy Inhibition of Membrane Fusion as a Target for Antiviral Therapy
Anti-Infective Agents in Medicinal Chemistry